NEWS
Genome Study Points to Treatments for High-Risk Form of Childhood Leukemia
Using genomic tools, researchers have uncovered genetic changes associated with a form of leukemia that recurs in some children.
The findings, reported last month in Cancer Cell, suggest that some of these young patients may benefit from targeted drugs that are available but currently not used to treat this particular form of the disease. Read more > >
High Breast Density Does Not Predict Death among Breast Cancer Patients
Patients with low-density breasts who are obese or have large tumors may be more likely to die of the diseaseFlavored Cigar Use Common among Young Adult Cigar Smokers
Women cigar smokers and those with lower incomes also more likely to use flavored cigarsGene in Stem Cell Donors May Decrease Relapse Risk in Leukemia Patients
Refined criteria for selecting stem-cell transplant donors could improve outcomes for AML patientsSequencing "Outlier" Genome Suggests Some Patients May Benefit from Cancer Drug
Gene mutation may identify bladder cancer patients likely to respond to targeted drugResearchers Use Gene Deletions to Find Cancer Treatment Targets
Approach highlights potential vulnerabilities in genes not involved in cancerAlso in the News: CDC Updates Hepatitis C Testing Recommendations
Also in the Journals: Youth Tobacco Use Dropped between 2000 and 2011
COMMENTARY
A Conversation with Dr. Louis Staudt about Targeting New Treatments for Burkitt Lymphoma
Dr. Louis Staudt of NCI's Center for Cancer Research and colleagues have confirmed that Burkitt lymphoma is molecularly distinct from other types of non-Hodgkin lymphoma. This discovery will help identify promising new targets for treatment.
IN DEPTH
Clinical Pathways in Cancer Care Catching On
Programs aim to help doctors choose best treatment optionsFeatured Clinical Trial: Targeting Invasive Glioma Cells
Will a new targeted drug be safe for patients with progressive glioblastoma?
UPDATES
FDA Update
- FDA Approves First Drug Developed for Children with Rare Brain Tumor
- New Treatment for Severe Neutropenia Approved
- FDA Approves Drug to Treat Rare Type of Leukemia
Cancer.gov Update
- New Website Highlights NCI-Designated Cancer Centers
- 2011/2012 Cancer Trends Progress Report Available
- Website for NCI's Geographic Information Systems & Science Updated
Notes
- In Memoriam: International Cancer Researcher Gregory T. O'Conor
- Cyber-Seminar: Bridging Cancer Research and Clinical Practice
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.